Literature DB >> 33167718

Outcome of hospitalized patients with hematological malignancies and COVID-19 infection in a large urban healthcare trust in the United Kingdom.

Catherine Garnett1, David Foldes1, Chris Bailey1, George Nesr1, Tracy Hui1, Richard Hinton1, Kamala Gurung1, James Phillips1, Zahbia Saleem1, Rincy Koshy1, Elvis Aduwa1, Marife Colis1, Ravi Bimolah1, Vaitsa Katsomitrou1, Siamak Arami1, Huseini Kagdi1.   

Abstract

Entities:  

Year:  2020        PMID： 33167718     DOI： 10.1080/10428194.2020.1838506

Source DB:  PubMed          Journal:  Leuk Lymphoma        ISSN： 1026-8022


× No keyword cloud information.
  4 in total

1.  The impact of anti-tumor approaches on the outcomes of cancer patients with COVID-19: a meta-analysis based on 52 cohorts incorporating 9231 participants.

Authors:  Qing Wu; Shuimei Luo; Xianhe Xie
Journal:  BMC Cancer       Date:  2022-03-04       Impact factor: 4.430

2.  Concurrent Lymphoma and COVID-19: Diagnostic and Therapeutic Challenges of High-Grade Lymphoma and COVID-19.

Authors:  Jasmin Hundal; Alexander R Vartanov; Kang Huh; Enrique Ballesteros; Victoria Forbes
Journal:  Cureus       Date:  2022-02-26

Review 3.  Impact of COVID-19 in patients with lymphoid malignancies.

Authors:  John Charles Riches
Journal:  World J Virol       Date:  2021-05-25

Review 4.  COVID 19 and febrile neutropenia: Case report and systematic review.

Authors:  Taner Kaya; Ahmet Dilek; Resat Ozaras; Ozlem Sahin Balcik; Hakan Leblebicioglu
Journal:  Travel Med Infect Dis       Date:  2022-03-07       Impact factor: 20.441
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.